Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying specific stocks in the market. We monitor 13F filings and institutional buying patterns because large investors often have superior information and research capabilities. We provide ownership data, fund flow analysis, and institutional positioning for comprehensive coverage. Follow institutional money with our comprehensive ownership tracking and analysis tools for smarter investment decisions.
ProMIS Neurosciences Inc. Common Shares (ON) (PMN) is trading at $10.88 as of 2026-04-08, marking a 0.73% decline in its latest session. This analysis explores key technical levels, prevailing market context, and potential near-term scenarios for the biotech stock, without providing investment recommendations or price forecasts. PMN’s recent price action has been largely range-bound, with limited company-specific news driving flows as of late, leading market participants to focus on technical ma
How does currency impact ProMIS (PMN) Stock | Price at $10.88, Down 0.73% - Low Risk Entry
PMN - Stock Analysis
4211 Comments
1816 Likes
1
Loranzo
Insight Reader
2 hours ago
That’s a mic-drop moment. 🎤
👍 263
Reply
2
Shakina
Consistent User
5 hours ago
Technical indicators suggest a continuation of the current trend.
👍 27
Reply
3
Sudan
New Visitor
1 day ago
Would’ve made a different call if I saw this earlier.
👍 107
Reply
4
Krysta
Community Member
1 day ago
Market breadth is positive, indicating healthy participation.
👍 111
Reply
5
Tanishia
New Visitor
2 days ago
Volatility is moderate, reflecting balanced investor sentiment.
👍 92
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.